Markedly decreased expression of glutathione S-transferase π gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis

A. Yokomizo, K. Kohno, M. Wada, M. Ono, C. S. Morrow, K. H. Cowan, M. Kuwano

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Buthionine sulfoximine (BSO) is a synthetic amino acid that irreversibly inhibits an enzyme, γ-glutamyl-cysteine synthetase (γ-GCS), which is a critical step in glutathione biosynthesis. We isolated three BSO-resistant sublines, KB/BSO1, KB/BSO2, and KB/BSO3, from human epidermoid cancer KB cells. These cell lines showed 10-to 13-fold higher resistance to BSO, respectively, and had collateral sensitivity to cisplatin, ethacrynic acid, and alkylating agents such as melphalan and nitrosourea. Cellular levels of glutathione S-transferase π (GST-π) and its mRNA in BSO-resistant cell lines were less than 10% of the parental cells. Nuclear run-on assay showed that the transcriptional activity of GST-π was decreased in BSO-resistant cells, and transient transfection of GST-π promoter-chloramphenicol acetyltransferase constructs revealed that the sequences between -130 and - 80 base pairs of the 5' flanking region were at least partially responsible for the decreased expression of the GST-π gene. By contrast, γ-GCS mRNA levels were 3-to 5-fold higher in resistant cell lines than in KB cells, and the γ-GCS gene was found to be amplified in the BSO-resistant cell lines. GST-π mRNA levels appeared to be inversely correlated with γ-GCS mRNA levels in BSO-resistant cells. We further established the transfectants, KB/BSO3-π1 and KB/BSO3-π2, that overexpressed GST-π, from KB/BSO3, after introducing a GST-π expression plasmid. These two transfectants had similar levels in γ-GCS mRNA, drug sensitivity to alkylating agents, and glutathione content as those of KB cells. These findings suggest that the cellular levels of GST-π and γ-GCS might be co-regulated in these novel BSO-resistant cells.

Original languageEnglish (US)
Pages (from-to)19451-19457
Number of pages7
JournalJournal of Biological Chemistry
Volume270
Issue number33
DOIs
StatePublished - Jan 1 1995

Fingerprint

Buthionine Sulfoximine
Glutathione Transferase
Glutathione
Genes
Cells
Cell Line
KB Cells
Neoplasms
Messenger RNA
Alkylating Agents
Ethacrynic Acid
Chloramphenicol O-Acetyltransferase
Melphalan
5' Flanking Region
Biosynthesis
Ligases
Base Pairing
Cisplatin
Transfection
Cysteine

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Markedly decreased expression of glutathione S-transferase π gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis. / Yokomizo, A.; Kohno, K.; Wada, M.; Ono, M.; Morrow, C. S.; Cowan, K. H.; Kuwano, M.

In: Journal of Biological Chemistry, Vol. 270, No. 33, 01.01.1995, p. 19451-19457.

Research output: Contribution to journalArticle

@article{0fa657855b11478190069e9342b6ffb9,
title = "Markedly decreased expression of glutathione S-transferase π gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis",
abstract = "Buthionine sulfoximine (BSO) is a synthetic amino acid that irreversibly inhibits an enzyme, γ-glutamyl-cysteine synthetase (γ-GCS), which is a critical step in glutathione biosynthesis. We isolated three BSO-resistant sublines, KB/BSO1, KB/BSO2, and KB/BSO3, from human epidermoid cancer KB cells. These cell lines showed 10-to 13-fold higher resistance to BSO, respectively, and had collateral sensitivity to cisplatin, ethacrynic acid, and alkylating agents such as melphalan and nitrosourea. Cellular levels of glutathione S-transferase π (GST-π) and its mRNA in BSO-resistant cell lines were less than 10{\%} of the parental cells. Nuclear run-on assay showed that the transcriptional activity of GST-π was decreased in BSO-resistant cells, and transient transfection of GST-π promoter-chloramphenicol acetyltransferase constructs revealed that the sequences between -130 and - 80 base pairs of the 5' flanking region were at least partially responsible for the decreased expression of the GST-π gene. By contrast, γ-GCS mRNA levels were 3-to 5-fold higher in resistant cell lines than in KB cells, and the γ-GCS gene was found to be amplified in the BSO-resistant cell lines. GST-π mRNA levels appeared to be inversely correlated with γ-GCS mRNA levels in BSO-resistant cells. We further established the transfectants, KB/BSO3-π1 and KB/BSO3-π2, that overexpressed GST-π, from KB/BSO3, after introducing a GST-π expression plasmid. These two transfectants had similar levels in γ-GCS mRNA, drug sensitivity to alkylating agents, and glutathione content as those of KB cells. These findings suggest that the cellular levels of GST-π and γ-GCS might be co-regulated in these novel BSO-resistant cells.",
author = "A. Yokomizo and K. Kohno and M. Wada and M. Ono and Morrow, {C. S.} and Cowan, {K. H.} and M. Kuwano",
year = "1995",
month = "1",
day = "1",
doi = "10.1074/jbc.270.33.19451",
language = "English (US)",
volume = "270",
pages = "19451--19457",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "33",

}

TY - JOUR

T1 - Markedly decreased expression of glutathione S-transferase π gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis

AU - Yokomizo, A.

AU - Kohno, K.

AU - Wada, M.

AU - Ono, M.

AU - Morrow, C. S.

AU - Cowan, K. H.

AU - Kuwano, M.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Buthionine sulfoximine (BSO) is a synthetic amino acid that irreversibly inhibits an enzyme, γ-glutamyl-cysteine synthetase (γ-GCS), which is a critical step in glutathione biosynthesis. We isolated three BSO-resistant sublines, KB/BSO1, KB/BSO2, and KB/BSO3, from human epidermoid cancer KB cells. These cell lines showed 10-to 13-fold higher resistance to BSO, respectively, and had collateral sensitivity to cisplatin, ethacrynic acid, and alkylating agents such as melphalan and nitrosourea. Cellular levels of glutathione S-transferase π (GST-π) and its mRNA in BSO-resistant cell lines were less than 10% of the parental cells. Nuclear run-on assay showed that the transcriptional activity of GST-π was decreased in BSO-resistant cells, and transient transfection of GST-π promoter-chloramphenicol acetyltransferase constructs revealed that the sequences between -130 and - 80 base pairs of the 5' flanking region were at least partially responsible for the decreased expression of the GST-π gene. By contrast, γ-GCS mRNA levels were 3-to 5-fold higher in resistant cell lines than in KB cells, and the γ-GCS gene was found to be amplified in the BSO-resistant cell lines. GST-π mRNA levels appeared to be inversely correlated with γ-GCS mRNA levels in BSO-resistant cells. We further established the transfectants, KB/BSO3-π1 and KB/BSO3-π2, that overexpressed GST-π, from KB/BSO3, after introducing a GST-π expression plasmid. These two transfectants had similar levels in γ-GCS mRNA, drug sensitivity to alkylating agents, and glutathione content as those of KB cells. These findings suggest that the cellular levels of GST-π and γ-GCS might be co-regulated in these novel BSO-resistant cells.

AB - Buthionine sulfoximine (BSO) is a synthetic amino acid that irreversibly inhibits an enzyme, γ-glutamyl-cysteine synthetase (γ-GCS), which is a critical step in glutathione biosynthesis. We isolated three BSO-resistant sublines, KB/BSO1, KB/BSO2, and KB/BSO3, from human epidermoid cancer KB cells. These cell lines showed 10-to 13-fold higher resistance to BSO, respectively, and had collateral sensitivity to cisplatin, ethacrynic acid, and alkylating agents such as melphalan and nitrosourea. Cellular levels of glutathione S-transferase π (GST-π) and its mRNA in BSO-resistant cell lines were less than 10% of the parental cells. Nuclear run-on assay showed that the transcriptional activity of GST-π was decreased in BSO-resistant cells, and transient transfection of GST-π promoter-chloramphenicol acetyltransferase constructs revealed that the sequences between -130 and - 80 base pairs of the 5' flanking region were at least partially responsible for the decreased expression of the GST-π gene. By contrast, γ-GCS mRNA levels were 3-to 5-fold higher in resistant cell lines than in KB cells, and the γ-GCS gene was found to be amplified in the BSO-resistant cell lines. GST-π mRNA levels appeared to be inversely correlated with γ-GCS mRNA levels in BSO-resistant cells. We further established the transfectants, KB/BSO3-π1 and KB/BSO3-π2, that overexpressed GST-π, from KB/BSO3, after introducing a GST-π expression plasmid. These two transfectants had similar levels in γ-GCS mRNA, drug sensitivity to alkylating agents, and glutathione content as those of KB cells. These findings suggest that the cellular levels of GST-π and γ-GCS might be co-regulated in these novel BSO-resistant cells.

UR - http://www.scopus.com/inward/record.url?scp=0029102099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029102099&partnerID=8YFLogxK

U2 - 10.1074/jbc.270.33.19451

DO - 10.1074/jbc.270.33.19451

M3 - Article

C2 - 7642628

AN - SCOPUS:0029102099

VL - 270

SP - 19451

EP - 19457

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 33

ER -